https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

6th edition of the NEXT-Val Call for young researchers

10 de March de 2020

The NEXT-VAL call promotes the development of translational research projects in the biosanitary environment of Cantabria, led by leading emerging researchers who have never accessed as such a competitive access aid. Requirements of the principal investigator: It will be necessary to have a principal investigator who has a labor, official or statutory relationship with the […]

Read more →

Canceled Next Session Progress Reports

9 de March de 2020

On March 11, the third session will take place within the IV Progress Report of the Valdecilla program, which will feature the presentations of Esther Setién and Veronica Pulito. CANCELLED “ Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort” Speaker: Esther Setién Suero Esther Setién is a doctor […]

Read more →

Analysis of the BAFF cytokine as a biomarker potential

The IDIVAL Transplant and Autoimmunity group, belonging to the Kidney Disease Research Network (REDINREN) funded by the ISCIII with FEDER funds, has published a recent work in its biomarker line of work associated with the clinical evolution of Renal Transplant. Renal transplantation is the best treatment for patients with advanced chronic kidney disease compared to […]

Read more →

Researchers at IDIVAL and CNIO find the molecular regulation that allows the skin to be continuously exposed to the sun

2 de March de 2020

The Cell Cycle, Determining Stem Cells and Cancer research group of the Valdecilla Health Research Institute (IDIVAL), led by Dr. Alberto Gandarillas, has just published a paper that includes the molecular regulation that makes it possible for epithelial cells such as skin epidermis do not die against continuous carcinogens such as sunlight. This discovery has […]

Read more →

Analysis of genotyping methodologies to detect RAS mutations

It is currently known that those patients with metastatic colorectal cancer (CCRm) whose tumors have mutations at the level of certain genes involved in the EGFR receptor pathway (HER-1), such as the RAS gene (KRAS or NRAS exons 2,3 and 4 ), do not benefit from therapy with monoclonal antibodies with antiEGFR activity (Cetuximab or […]

Read more →

Conference on Hepatocarcinoma Multidisciplinary approach in 2020

24 de February de 2020

Hepatocarcinoma is a challenge in all aspects such as diagnosis, staging or selection of the best treatment for each patient. In a few disorders like this one and in all the phases of their attention, the collaboration of several specialties is necessary. Therefore, and with the double objective of updating the latest technical knowledge and […]

Read more →

Diagnostic value of bone marrow biopsy in patients with lymphoplasmacytic B lymphoma

The article “Diagnostic value of Bone marrow core biopsy patterns in Lymphoplasmacytic Lymphoma / Waldeström Macroglobulinemia and description of its mutational profiles by targeted NGS” has recently been published in the international Journal of Clinical Pathology (FI 2,346, JCR). This original manuscript describes the clinical relevance of the evaluation by multiparameter methods (morphology and histopathology, […]

Read more →

Leonado-BBVA Foundation Scholarships

21 de February de 2020

The Leonardo Scholarships for Researchers and Cultural Creators granted by the BBVA Foundation are intended to directly support the work of researchers and cultural creators between 30 and 45 years of age who, being in the middle stages of their career, develop a markedly personal and innovative project in the corresponding area of specialization or […]

Read more →

Next Santander Biomedical Lectures conference

20 de February de 2020

Next Thursday, February 27, the next conference of the fourth edition of the Santander Biomedical Lectures program organized by IDIVAL, the University of Cantabria and the IBBTEC given by Dr. Martin will be held with the title “MTBVAC a new vaccine against tuberculosis, from laboratory to clinical trials of efficacy in endemic countries ”. Carlos […]

Read more →

2 units of IDIVAL and 18 of Valdecilla with ISO quality certifications

The User Care, Immunology and Radiodiagnostic Services of the Marqués de Valdecilla University Hospital have received the ISO 9001: 2015 accreditation, which certifies their commitment to quality and safety in the framework of continuous improvement to achieve the best health results. With these three new accreditations, Valdecilla brings to 20 the number of services and […]

Read more →